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Abstract 
 
Paraneoplastic syndrome (PNS) is a distant neurological manifestation of an underlying tumour. Humoral 
hypercalcaemia of malignancy is a form of paraneoplastic syndrome where there is an increased in calcium levels. In 
this article we report a 48 year old lady, with no known medical illness and presented with symptomatic 
hypercalcaemia. She presented to our institution complaining of a fungating and ulcerating mass over the right 
breast, measuring 11 X 15 cm and associated with gradual paraxial body weakness. Further investigations revealed 
the lesion to be an invasive breast carcinoma with metaplastic features. Computed tomography (CT) scan showed a 
locally advanced breast carcinoma with right axillary node metastasis, without evidence of distant metastasis. Serum 
calcium, i-PTH together with SPECT has confirmed the patient to have a humoral hypercalcaemia malignancy with 
elevated ectopic parathyroid hormone level. Bone scan did not reveal any evidence of metastasis. High volume 
intake and loop diuretics were employed in the management of hypercalcaemia, which was eventually resolved 
following mastectomy with axillary clearance of the ipsilateral side. Currently she’s she is under oncologist’s follow 
up for further management. 
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Introduction 
 
It was recognised in the past century that some 
tumours can lead to a group of signs and symptoms 
that are not related to a direct hematological, 
lymphatic or compression by the cancer growth. This 
was attributed to rather humoral (hormonal and 
peptide) secretions from the cancer cells or in other 
cases by immune responses against the tumour itself 
(1). Collectively, those signs and symptoms were 
referred to as Paraneoplastic syndrome (PNS). Nearly 
all of the PNS cases are associated with breast, 
ovarian, lung or lymphatic cancers (2). Patients with 
paraneoplastic syndrome may have neurological, 
endocrine, mucocutaneous or even hematological 
manifestations. 
 
About 8% of cancer patients have associated 
paraneoplastic syndrome. In some occasions, cancer 
patients present with paraneoplastic manifestations 
prior to detection of the tumour, such symptoms when 
detected may raise the suspicion for occult cancer. 
Humoral hypercalcaemia of malignancy (HHM) is a 
common paraneoplastic condition, which occur in 20% 
of paraneoplastic patients (3). Most of these patients 
present with or have an underlying breast cancer, lung 
cancer or multiple myeloma. Hypercalcaemia maybe 
attributed to several mechanisms, including; first, 
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release of parathyroid hormone-related protein 
(PTHrP) (4,5) which accounts for the majority of the 
cases reported; second, an ectopic parathyroid 
hormone (PTH) secreting tumour which is a rare 
condition and last but not least due to  1 a-hydroxylase 
activity tumour that produce 1,25-dihydroxyvitamin D 
and bone metastasis and skeletal osteolysis tumour s 
(6). This case highlighted an example of PNS 
presented with hypercalcaemia, in a patient with 
locally advanced breast cancer. 
 
Case Report 
 
A 48-year-woman, with no underlying medical illness, 
had a previous history of Total Abdominal 
Hysterectomy Bilateral Salpingo Oophorectomy 
(TAHBSO) due to uterine fibroid at the age of 45. The 
patient first noticed a right breast lump over the last 
two years but unfortunately she did not seek any 
professional medical advice but resorted to traditional 
medicine and therapy. The lump gradually grew in size 
during those two years. She also had weight loss 
together with reduced in appetite along with 
generalized body weakness. 
 
She only presented to us in July 2015 with a fungating 
and ulcerating right breast mass measuring around 11 
X 15 cm. The wedge biopsy of the lesion reported as 
invasive carcinoma with metaplastic features. 
Immunohistochemical studies of the biopsy proven the 
malignant cells to be positive for Estrogen Receptor 
(ER) with 10% positivity and strong intensity, and 
negative for Progesterone Receptor (PR) and (human 
epidermal growth factor receptor 2(HER2) CT staging 
did not show any distant metastases and she was 
advised for neoadjuvant chemotherapy.  She refused 
chemotherapy and decided to take only tamoxifen. She 
was lost to follow up and presented at a different 
hospital with progressive body weakness and 
confusion. CT scan of the brain was normal and again 
family members decided to seek traditional treatment. 
The condition worsened and she was brought back to 
the hospital. Clinically, she was confused and 
disorientated. There was generalized oedema. 
Examination of the breast revealed a fungating right 
breast lesion. There was no specific bony tenderness 
except from generalized body ache. Laboratory 
Investigation done showed she was anaemic with 
severe hypoalbuminaemia and hypercalcaemia ranging 
from 2.5-3.1 mmol/L. Among the radiological 
investigations a repeat CT scan confirmed that it was a 
locally advanced breast carcinoma with right axillary 
lymph node metastases. In addition, there were 
multiple hypoechoic lesions at segments V and VII of 
the liver and a small lung nodule which did not 
suggest malignant infiltration. The serum i-PTH was 
elevated (13.53 pmol/L) with normal serum 
phosphorus and Vitamin D. A 99mTc-Methyl 
diphosphonate (Tc99m MDP) whole body bone scan 
with single photon emission computed tomography 
(SPECT) was done but did not show any evidence of 
skeletal metastases. The patient was diagnosed with 
Humoral hypercalcaemia of malignancy and treated 
with saline infusion and intravenous Zolendronic acid. 
The calcium returned to normal and she became 
orientated and not drowsy anymore.  
 
In view of persistent bleeding and massive loss of 
proteinaceous fluid from the tumour, the patient was 
counseled for right breast mastectomy which was 
agreeable. A debulking mastectomy with primary skin 
closure was performed as the axillary nodes were 
encasing the axillary vessels. The final histology 
confirmed a metaplastic carcinoma (squamous cell 
carcinoma), Bloom and Richardson grade III. On 
immunohistochemical study; the malignant cells were 
positive to p63, CKMNF, CK5 and CK6. The serum 
calcium post-op dropped to (1.8- 1.9 mmol/L) and her 
hypoalbuminaemia improved dramatically. 
Unfortunately, she refused further treatment and 
represented a month later presented with chest wall 
recurrence and currently undergoing chemotherapy. 
 
Discussion 
 
Though paraneoplastic syndrome has been identified 
during the middle of the last century, it hasn’t been 
fully discovered and understood until nowadays (7). 
Nevertheless, it is undeniable that the number of the 
cancer patients has increased over the past few 
decades. In return, it is expected to come across more 
cases that resemble or might add to our knowledge of 
PNS pathogenesis, methods of therapy and early 
diagnosis, all of which will contribute to a better 
prognosis and improve the life expectancy for the 
patients. 
 
Most of PNS cases are associated with neurological 
disorders that present in either known cancer cases or 
those with occult tumours (8). Those disorders have 
been related to the tumour producing antibodies that 
target the nervous system as for an example Anti-Ro, 
Anti-Ma, Anti-Hu and Anti-Yo. Some other cases 
have been suggested to be caused by an autoimmune 
response of T-cells which attack the nervous system 
due to the resemblance between it and the tumour’s 
antibody (9). 
 
Humoral hypercalcaemia of malignancy (HHM) is a 
paraneoplastic syndrome that is most commonly 
associated with breast cancer and presents with 
hypercalcemia. Though there are few possible reasons 
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to which elevated serum calcium level can be 
attributed to, the most common cause remains the 
secretion of parathyroid hormone related protein 
(PTHrP). This osteolytic effect resulted from 
metastasis or due to the effect of 1 a-hydroxylase 
produced by certain types of tumours. Ectopic 
secretion of PTH is a rare condition that has been 
reported in few cases up to date (3,10). 
 
Though breast cancers have been associated with 
hyperparathyroidism and hypercalcaemia, the reason 
behind this correlation is yet to be understood (11). 
Some studies suggested the possibility of breast cancer 
associated hypercalcaemia to lead to 
hyperparathyroidism due to parathyroid adenoma and 
vice versa (12). 
 
In this paper, we present a middle-aged lady with 
metaplastic breast cancer with an ectopic PTH-like 
hormone secretion by the tumour. This is supported by 
the evidence of hypercalcaemia and elevated 
parathyroid hormone level and normal bone scan. 
Unfortunately, we could not proceed with 
immunohistochemistry evaluation for anti-PTH and 
PTHrP of our tissue samples due to unavailability 
these tests neither in our center nor in other 
pronounced medical centers. In our search for 
literature and case reports discussing ectopic 
parathyroid hormone producing tumours, there were a 
few case reports describing parathyroid hormone 
secreting lung carcinoma, thyroid carcinoma, 
pancreatic and other GI related malignancies and 
ovarian carcinomas (13). There was only a single case 
report published suggesting the association between 
ectopic parathyroid hormone secretion and breast 
carcinoma (14) making our case as the second. 
Following mastectomy of and axillary dissection of the 
affected side the patient serum calcium level dropped 
to 1.8-1.9 mmol/l along with normal PTH level, which 
concluded the ectopic source of PTH. 
 
Conclusion 
 
Secondary bone metastases contribute to the majority 
of causes for hypercalcaemia in breast cancer. 
Although being infrequent, humoral hypercalcaemia of 
malignancy is a rare event, which should be 
thoroughly investigated in patients with breast cancer. 
Parathyroid adenoma may co-exist with breast cancer 
and need to be excluded. Having an elevated serum 
calcium level can be attributed to few etiologies and 
HHM not to be overlooked despite its rarity. 
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